GITNUXREPORT 2025

Radiation Therapy Statistics

Radiation therapy effectively treats cancer, with growing global access and technological advances.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

Approximately 50% of all cancer patients in the United States receive radiation therapy at some point during their treatment

Statistic 2

The global radiation therapy market was valued at around $7.6 billion in 2020 and is expected to grow significantly by 2028

Statistic 3

The average dose of radiation given during treatment varies between 45-70 Gy depending on the type and stage of cancer

Statistic 4

About 10% of all cancer cases worldwide are treated with radiation therapy

Statistic 5

The typical duration of a radiation therapy course ranges from 2 to 8 weeks, depending on the treatment plan

Statistic 6

Radiation therapy can be used as a curative treatment in approximately 40% of cancer cases

Statistic 7

The use of hypofractionation, delivering larger doses over fewer sessions, has increased by 25% for breast cancer treatments in recent years

Statistic 8

About 5% of all cancer patients are treated with gamma knife radiosurgery, especially for brain tumors and vascular malformations

Statistic 9

The use of stereotactic radiosurgery has increased by over 30% in the last decade

Statistic 10

The cost of a full course of radiation therapy for prostate cancer can range from $10,000 to $50,000 USD

Statistic 11

The number of patients receiving proton therapy in the U.S. increased by 15% annually from 2010 to 2020

Statistic 12

Radiation therapists are trained health professionals and typically require an associate degree or higher, with a median salary of $85,560 in the US in 2021

Statistic 13

Over 200 radiation therapy centers are operational across India, providing increasing access to cancer treatments

Statistic 14

The global burden of cancer is projected to increase by 50% over the next 20 years, amplifying the need for effective radiation therapy services

Statistic 15

The use of cobalt-60 units in radiation therapy has declined by approximately 80% since the 2000s due to the rise of linear accelerators

Statistic 16

About 70% of patients with early-stage prostate cancer are treated successfully with radiation therapy

Statistic 17

The five-year survival rate for localized non-small cell lung cancer treated with radiation is approximately 35-45%

Statistic 18

Intensity-modulated radiation therapy (IMRT) has demonstrated a decrease in side effects compared to conventional radiation therapy in 65% of cases

Statistic 19

Stereotactic body radiation therapy (SBRT) has a local control rate of over 85% in early-stage lung cancer

Statistic 20

About 20-30% of all cancer-related deaths are attributed to the failure of radiation therapy or inoperable tumors resistant to treatment

Statistic 21

The rate of local tumor control improves significantly with combined surgery and radiation therapy in certain cancers, such as head and neck cancers

Statistic 22

The average age of patients receiving radiation therapy for cancer treatment is approximately 60 years old, reflecting the prevalence of cancer in older adults

Statistic 23

Radiation therapy can increase the effectiveness of immunotherapy in certain cancers, combining to improve survival rates

Statistic 24

The success rate of curative radiation therapy for early-stage anal cancer exceeds 80%, depending on the stage and treatment protocol

Statistic 25

About 90% of radiation oncologists report improvements in patient outcomes with the adoption of advanced technology like IMRT and VMAT

Statistic 26

The 10-year survival rate for localized breast cancer treated with radiation therapy is around 80-90%, demonstrating its effectiveness

Statistic 27

Radiation therapy is used as palliative treatment in about 40% of advanced cancer cases to relieve symptoms and improve quality of life

Statistic 28

The development of adaptive radiotherapy protocols has shown to improve tumor control by up to 15% in certain tumor sites

Statistic 29

Patients with head and neck cancers treated with combined chemoradiation have a 5-year survival rate exceeding 60%, depending on stage and treatment regimen

Statistic 30

The side effects of radiation therapy can include fatigue, skin changes, and localized hair loss, affecting approximately 70% of patients during treatment

Statistic 31

The risk of secondary cancers after radiation therapy is significantly higher in children, with an estimated 3-4% over lifetime exposure

Statistic 32

Approximately 60% of patients undergoing radiation therapy experience acute side effects, which typically resolve within weeks after treatment completion

Statistic 33

Approximately 15% of cancer patients experience radiation-related fatigue that persists up to 6 months post-treatment

Statistic 34

Proton therapy, a type of advanced radiation therapy, offers high precision and can reduce damage to surrounding healthy tissues

Statistic 35

The development of image-guided radiation therapy (IGRT) has improved targeting accuracy by up to 90%

Statistic 36

3D conformal radiation therapy was developed in the 1980s and marked a significant advancement in dose delivery precision

Statistic 37

The implementation of adaptive radiation therapy (ART) has increased, allowing personalized adjustments during treatment to improve outcomes

Statistic 38

Advances in imaging have reduced the percentage of missed tumors during radiation planning from 15% to less than 2%, improving treatment accuracy

Statistic 39

The use of volumetric modulated arc therapy (VMAT) has increased by 40% in the last five years, due to its efficiency and precision

Statistic 40

The average treatment planning time for radiation therapy is approximately 2-4 hours, depending on tumor complexity

Statistic 41

The introduction of 4D imaging in radiation therapy has reduced the necessary margin for tumor movement from 10mm to less than 3mm, increasing accuracy

Statistic 42

The implementation of MRI-guided radiation therapy (MRIgRT) has improved soft tissue visualization, leading to better tumor targeting and sparing of healthy tissue

Statistic 43

Radiation therapy plans are now increasingly personalized utilizing genetic markers to predict patient responses, improving precision medicine

Slide 1 of 43

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

Approximately 50% of all cancer patients in the United States receive radiation therapy at some point during their treatment
The global radiation therapy market was valued at around $7.6 billion in 2020 and is expected to grow significantly by 2028
About 70% of patients with early-stage prostate cancer are treated successfully with radiation therapy
The use of stereotactic radiosurgery has increased by over 30% in the last decade
The five-year survival rate for localized non-small cell lung cancer treated with radiation is approximately 35-45%
The average dose of radiation given during treatment varies between 45-70 Gy depending on the type and stage of cancer
About 10% of all cancer cases worldwide are treated with radiation therapy
Intensity-modulated radiation therapy (IMRT) has demonstrated a decrease in side effects compared to conventional radiation therapy in 65% of cases
Proton therapy, a type of advanced radiation therapy, offers high precision and can reduce damage to surrounding healthy tissues
The typical duration of a radiation therapy course ranges from 2 to 8 weeks, depending on the treatment plan
The side effects of radiation therapy can include fatigue, skin changes, and localized hair loss, affecting approximately 70% of patients during treatment
Stereotactic body radiation therapy (SBRT) has a local control rate of over 85% in early-stage lung cancer
The cost of a full course of radiation therapy for prostate cancer can range from $10,000 to $50,000 USD

Radiation therapy, a cornerstone in cancer treatment, now reaches over half of all cancer patients in the U.S. and is rapidly evolving with advanced technologies that promise higher success rates, fewer side effects, and personalized care, all amid a global cancer burden projected to rise by 50% over the next two decades.

Cancer Treatment Modalities and Advances

Approximately 50% of all cancer patients in the United States receive radiation therapy at some point during their treatment
The global radiation therapy market was valued at around $7.6 billion in 2020 and is expected to grow significantly by 2028
The average dose of radiation given during treatment varies between 45-70 Gy depending on the type and stage of cancer
About 10% of all cancer cases worldwide are treated with radiation therapy
The typical duration of a radiation therapy course ranges from 2 to 8 weeks, depending on the treatment plan
Radiation therapy can be used as a curative treatment in approximately 40% of cancer cases
The use of hypofractionation, delivering larger doses over fewer sessions, has increased by 25% for breast cancer treatments in recent years
About 5% of all cancer patients are treated with gamma knife radiosurgery, especially for brain tumors and vascular malformations

Cancer Treatment Modalities and Advances Interpretation

With half of all U.S. cancer patients undergoing radiation therapy—an industry valued at $7.6 billion globally and steadily evolving—this precise, adaptable, and sometimes groundbreaking treatment remains a cornerstone in the fight against cancer, demonstrating that in oncology, sometimes more is a little less—less time, more impact.

Market Trends and Economic Factors

The use of stereotactic radiosurgery has increased by over 30% in the last decade
The cost of a full course of radiation therapy for prostate cancer can range from $10,000 to $50,000 USD
The number of patients receiving proton therapy in the U.S. increased by 15% annually from 2010 to 2020
Radiation therapists are trained health professionals and typically require an associate degree or higher, with a median salary of $85,560 in the US in 2021
Over 200 radiation therapy centers are operational across India, providing increasing access to cancer treatments
The global burden of cancer is projected to increase by 50% over the next 20 years, amplifying the need for effective radiation therapy services
The use of cobalt-60 units in radiation therapy has declined by approximately 80% since the 2000s due to the rise of linear accelerators

Market Trends and Economic Factors Interpretation

As the sophistication, accessibility, and demand for radiation therapy surge—highlighted by a 30% rise in stereotactic radiosurgery and expanding global centers—costs and technological shifts, such as replacing cobalt-60 units with linear accelerators, underscore an evolving landscape where advanced treatment options come with both financial and professional implications for the fight against cancer.

Patient Outcomes and Survival Rates

About 70% of patients with early-stage prostate cancer are treated successfully with radiation therapy
The five-year survival rate for localized non-small cell lung cancer treated with radiation is approximately 35-45%
Intensity-modulated radiation therapy (IMRT) has demonstrated a decrease in side effects compared to conventional radiation therapy in 65% of cases
Stereotactic body radiation therapy (SBRT) has a local control rate of over 85% in early-stage lung cancer
About 20-30% of all cancer-related deaths are attributed to the failure of radiation therapy or inoperable tumors resistant to treatment
The rate of local tumor control improves significantly with combined surgery and radiation therapy in certain cancers, such as head and neck cancers
The average age of patients receiving radiation therapy for cancer treatment is approximately 60 years old, reflecting the prevalence of cancer in older adults
Radiation therapy can increase the effectiveness of immunotherapy in certain cancers, combining to improve survival rates
The success rate of curative radiation therapy for early-stage anal cancer exceeds 80%, depending on the stage and treatment protocol
About 90% of radiation oncologists report improvements in patient outcomes with the adoption of advanced technology like IMRT and VMAT
The 10-year survival rate for localized breast cancer treated with radiation therapy is around 80-90%, demonstrating its effectiveness
Radiation therapy is used as palliative treatment in about 40% of advanced cancer cases to relieve symptoms and improve quality of life
The development of adaptive radiotherapy protocols has shown to improve tumor control by up to 15% in certain tumor sites
Patients with head and neck cancers treated with combined chemoradiation have a 5-year survival rate exceeding 60%, depending on stage and treatment regimen

Patient Outcomes and Survival Rates Interpretation

While radiation therapy boasts impressive five-year survival rates exceeding 80-90% for localized breast and anal cancers and over 85% local control in early-stage lung cancer, about 20-30% of cancer-related deaths still stem from resistant tumors or treatment failures, reminding us that even in the realm of high-tech precision, cancer remains a formidable and stubborn adversary.

Side Effects, Risks, and Supportive Care

The side effects of radiation therapy can include fatigue, skin changes, and localized hair loss, affecting approximately 70% of patients during treatment
The risk of secondary cancers after radiation therapy is significantly higher in children, with an estimated 3-4% over lifetime exposure
Approximately 60% of patients undergoing radiation therapy experience acute side effects, which typically resolve within weeks after treatment completion
Approximately 15% of cancer patients experience radiation-related fatigue that persists up to 6 months post-treatment

Side Effects, Risks, and Supportive Care Interpretation

While radiation therapy offers hope against cancer, a sobering 70% of patients grapple with side effects like fatigue and skin changes, and for children in particular, the elevated lifetime risk of secondary cancers underscores the importance of weighing immediate benefits against long-term consequences.

Technological Innovations and Techniques

Proton therapy, a type of advanced radiation therapy, offers high precision and can reduce damage to surrounding healthy tissues
The development of image-guided radiation therapy (IGRT) has improved targeting accuracy by up to 90%
3D conformal radiation therapy was developed in the 1980s and marked a significant advancement in dose delivery precision
The implementation of adaptive radiation therapy (ART) has increased, allowing personalized adjustments during treatment to improve outcomes
Advances in imaging have reduced the percentage of missed tumors during radiation planning from 15% to less than 2%, improving treatment accuracy
The use of volumetric modulated arc therapy (VMAT) has increased by 40% in the last five years, due to its efficiency and precision
The average treatment planning time for radiation therapy is approximately 2-4 hours, depending on tumor complexity
The introduction of 4D imaging in radiation therapy has reduced the necessary margin for tumor movement from 10mm to less than 3mm, increasing accuracy
The implementation of MRI-guided radiation therapy (MRIgRT) has improved soft tissue visualization, leading to better tumor targeting and sparing of healthy tissue
Radiation therapy plans are now increasingly personalized utilizing genetic markers to predict patient responses, improving precision medicine

Technological Innovations and Techniques Interpretation

Advancements in radiation therapy—from 3D conformal techniques of the 1980s to today's MRI-guided and genetically tailored approaches—highlight a relentless pursuit of precision that transforms cancer treatment into a targeted art form, minimizing collateral damage while maximizing therapeutic impact.